FDA clears Abbott's wireless point-of-care test

Jeff Byers | | Health Exec | Precision Medicine
Abbott has received clearance from the FDA to begin marketing i-STAT 1 Wireless, a wireless version of the company's point-of-care testing system.

The wireless system will enable real-time transmission of diagnostic test results generated by i-STAT 1 directly from the patient bedside, the Princeton, N.J.-based pharmaceutical company stated. Sharing test results via a hospital's wireless network, caregivers will have more rapid access to information, Abbott added.

The i-STAT 1 Wireless handheld is certified for compatibility with existing wireless networks and is compatible with point-of-care data management systems used with earlier versions of the i-STAT System, Abbott said.

Jeff Byers

Related Content

Pitching the business case for 3D printing labs in radiology
FDA issues first-ever clearance for OTC oximeter
Augmented reality company secures $15M in funding from Cleveland Clinic, Mayo, GE Healthcare and more
Merck to acquire Prometheus Biosciences for $10.8B
Johnson & Johnson scraps RSV vaccine after trial
Intermountain Health launches new biotech company

Around the web

AI in Healthcare
4 ways HHS plans to help shape a national strategy for healthcare AI

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.

Cardiovascular Business
FDA announces recall after Philips heart monitor software failed to send alerts—multiple deaths reported

Philips is recalling the software associated with its Mobile Cardiac Outpatient Telemetry devices after certain high-risk ECG events were never routed to trained cardiology technicians as intended. The issue, which lasted for two years, has been linked to more than 100 injuries. 

Cardiovascular Business
Why electrophysiologists needed a champion in Washington

Heart Rhythm Society President Kenneth A. Ellenbogen, MD, detailed a new advocacy group focused on improving EP reimbursements, patient care and access. “If you’re not at the table, you’re on the menu," he said.